Esben Selmer Selmer Buhl (Esben Selmer Buhl)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Skeletal Muscle

Glycemic Control

Palliative Care

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jannicke Igland, Rachel Forster, Anne Karen Jenum, Ragnhild B Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein Memelink Iversen, Esben Selmer Selmer Buhl
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ open 14 (3) (2024)
Jannicke Igland, Rachel Forster, Anne Karen Jenum, Ragnhild B Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein Memelink Iversen, Esben Selmer Selmer Buhl
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ open 14 (3) (2024)
Jannicke Igland, Rachel Forster, Anne Karen Jenum, Ragnhild B Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein Memelink Iversen, Esben Selmer Selmer Buhl
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ open 14 (3) (2024)
Jannicke Igland, Rachel Forster, Anne Karen Jenum, Ragnhild B Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein Memelink Iversen, Esben Selmer Selmer Buhl
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ open 14 (3) (2024)
Rachel B Forster, Ragnhild B Strandberg, Katrina Louise Bø Tibballs, Kjersti Nøkleby, Tore Julsrud Berg, Tor Iversen, Terje P Hagen, Kåre Rønn Richardsen, John Cooper, Sverre Sandberg, Karianne Fjeld Løvaas, Roy Miodini Nilsen, Marjolein Memelink Iversen, Anne Karen Jenum, Esben Selmer Selmer Buhl
Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway. BMJ open 12 (5) (2022)